Related Experiment Video
Updated: Jun 29, 2025

07:25
A Bioluminescent and Fluorescent Orthotopic Syngeneic Murine Model of Androgen-dependent and Castration-resistant Prostate Cancer
Published on: March 6, 2018
13.1K
A resource-based mechanistic framework for castration-resistant prostate cancer (CRPC)
B Vibishan1, Harshavardhan B V2, Sutirth Dey1
1Department of Biology, Indian Institute of Science Education and Research (IISER) Pune, Pune, Maharashtra, India.
Journal of Theoretical Biology
|April 4, 2024
Summary
Tumour relapse in castration-resistant prostate cancer (CRPC) can be delayed by modeling resource dynamics. Understanding oxygen and testosterone availability and utilization is key to managing CRPC cell competition and growth.
Area of Science:
- Cancer Ecology
- Mathematical Oncology
- Prostate Cancer Research
Background:
- Cancer therapies can eliminate sensitive cells, promoting resistant cell growth and tumour relapse.
- Castration-resistant prostate cancer (CRPC) exemplifies this, where resistant cells produce testosterone after androgen deprivation therapy (ADT), leading to regrowth.
Purpose of the Study:
- To develop a theoretical model for intra-tumour competition in CRPC, focusing on resource dynamics.
- To investigate how resource availability and utilization influence the steady-state composition of CRPC.
Main Methods:
- Utilized a modified logistic framework to model cell-cell interactions based on resource production and consumption.
- Analyzed the impact of oxygen and testosterone availability and utilization efficiency on CRPC dynamics.
Main Results:
- CRPC steady-state composition is a function of oxygen and testosterone availability and utilization efficiency.
- Resource abundance regimes (trace vs. high levels) differentially affect CRPC behavior, with testosterone having a distinct impact compared to oxygen.
Conclusions:
- Explicit consideration of resource dynamics offers novel mechanistic insights into CRPC.
- This modeling approach integrates clinically measurable variables, paving the way for CRPC therapies rooted in tumor ecology.

